SMS Shareholders To Consider Eclipsys-Nominated Slate Of Directors May 16
This article was originally published in The Gray Sheet
Executive Summary
Shared Medical Systems' May 16 annual shareholder meeting agenda will include consideration of a rebel slate of director candidates to be nominated by rebuffed suitor Eclipsys.
You may also be interested in...
Eclipsys Ends SMS Takeover Bid After Agreeing To Neoforma.com Merger
Eclipsys effectively ended its takeover bid for rival healthcare IT provider Shared Medical Systems by withdrawing plans to propose a rebel slate of director candidates at SMS' annual shareholder meeting, following its decision to merge with online medical supply company Neoforma.com.
Eclipsys Ends SMS Takeover Bid After Agreeing To Neoforma.com Merger
Eclipsys effectively ended its takeover bid for rival healthcare IT provider Shared Medical Systems by withdrawing plans to propose a rebel slate of director candidates at SMS' annual shareholder meeting, following its decision to merge with online medical supply company Neoforma.com.
Shared Medical Systems Corp.
Anti-takeover shareholder rights plan is amended to delete all provisions requiring certain actions under the plan to be authorized by "continuing directors," the firm announces March 20. The order was taken to "conform the terms of the plan to recent decisions by the Delaware courts." Rebuffed suitor Eclipsys, which launched an unsolicited $2 bil. merger proposal March 2, had filed suit in Delaware Chancery Court challenging the legality of the "continuing director provision" of SMS' "poison pill" shareholder rights plan (1"The Gray Sheet" March 13, p. 14). SMS has scheduled its annual shareholders meeting for June 9, instead of May 16 as previously anticipated, to allow more time for the firm to evaluate various strategic alternatives